HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

218.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 325.00
  • 52 Week Low: 189.00
  • Currency: UK Pounds
  • Shares Issued: 872.11m
  • Volume: 10,502
  • Market Cap: £1,901.20m
  • RiskGrade: 226

HCM Overview

HUTCHMED (China) Limited is in the pharma and biotech sector and is currently trading at 218.00p per share. In the last year HUTCHMED (China) Limited's share price has ranged from 189.00p to 325.00p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 6.6% n/a
ROCE n/a  
Latest F'cast
P/E 73.9 n/a
PEG n/a n/a
Pr/Revenue 4.1 n/a
Pr/Book 3.3  
Latest F'cast
Revenue -24.8% n/a
PBT n/a n/a
EPS -66.7% n/a
DPS n/a n/a

HCM Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 227.98 (189.73) (18.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 356.13 (215.74) (0.25)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 426.41 (410.42) (43.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 838.00 58.31 12.00¢ 31.7 n/a n/a n/a 0.0%
31-Dec-24 630.20 (1.11) 4.00¢ 79.0 n/a -67% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HCM Company Announcements

Directorate Change 26-Aug-2025 07:00 RNS
2025 Interim Results 07-Aug-2025 12:00 RNS
HUTCHMED to Announce 2025 Half-Year Results 03-Jul-2025 09:30 RNS

HCM ShareCast News

Hutchmed enrols last patient in phase 3 lung can... 20-Aug-2025 ShareCast
Hutchmed to get milestone payment after China dr... 30-Jun-2025 ShareCast
Hutchmed new drug application accepted in China 05-Jun-2025 ShareCast

HCM Top Newspaper Links

Chinese medicine firm employs Cambridge Universi... 23-Dec-2009 Guardian
Joint venture offers food for growth 09-Oct-2009 The Scotsman
Chi-Med unveils maiden profit 31-Jul-2009 The Scotsman

Latest HCM Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HCM Market Data

Currency UK Pounds
Share Price 218.00p
Change Today -0.50p
% Change -0.23 %
52 Week High 325.00
52 Week Low 189.00
Volume 10,502
Shares Issued 872.11m
Market Cap £1,901.20m
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.68% below the market average43.68% below the market average43.68% below the market average43.68% below the market average43.68% below the market average
31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average
Price Trend
21.97% below the market average21.97% below the market average21.97% below the market average21.97% below the market average21.97% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Income Not Available
Growth
44.06% below the market average44.06% below the market average44.06% below the market average44.06% below the market average44.06% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average

HCM Dividends

No dividends found

Trades for 29-Aug-2025

Time Volume / Share Price
12:34 8 @ 218.00p
12:34 1,605 @ 218.00p
12:34 20 @ 218.00p
11:50 5 @ 231.95p
09:08 1 @ 218.00p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page